T-DM1
New Antibody Drug Conjugate May Become Metastatic Breast Cancer Standard
For second-line treatment of metastatic HER2-positive breast cancer, the new-generation antibody drug conjugate ...
DECEMBER 16, 2021
How I Manage Adjuvant Therapy in HER2-Positive Breast Cancer
Adjuvant anti-HER2 therapy in combination with chemotherapy has markedly improved disease-free survival and overall ...
JULY 12, 2017
T-DM1 No Better Than Taxane in Advanced Gastroesophageal Cancer
A Phase III trial has shown T-DM1 is no better than a taxane for patients with HER2-positive, locally advanced ...
JANUARY 27, 2016
Load more